VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)

CUSIP: 92532F100

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock
Shares outstanding
254,691,824
Total 13F shares
245,828,310
Share change
+131,897
Total reported value
$41,645,081,563
Put/Call ratio
123%
Price per share
$169.42
Number of holders
696
Value change
+$11,091,504
Number of buys
346
Number of sells
300

Quarterly Holders Quick Answers

What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q3 2019

As of 30 Sep 2019, VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by 696 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 245,828,310 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, JENNISON ASSOCIATES LLC, RENAISSANCE TECHNOLOGIES LLC, and ALLIANCEBERNSTEIN L.P.. This page lists 697 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.